Key result
Implanting CIEDs for subclinical AF detection or initiating OAC shows no clinical benefit.
Why the study?
Does oral anticoagulation therapy improve outcomes in patients with subclinical atrial fibrillation detected by cardiovascular implantable electronic devices?
Population
Patients with subclinical atrial fibrillation detected by cardiovascular implantable electronic devices
Design
Review
Authors
Loading...
Does not support routine anticoagulation for CIED-detected subclinical AF; leaves open whether ongoing trials will alter practice.
Does oral anticoagulation therapy improve outcomes in patients with subclinical atrial fibrillation detected by cardiovascular implantable electronic devices?
There is currently no direct evidence supporting the routine use of oral anticoagulation for subclinical AF detected by CIEDs, highlighting the need for ongoing trials.
Hess et al. (2017) conducted a review in Subclinical atrial fibrillation. Cardiovascular implantable electronic devices (CIEDs) and oral anticoagulation was evaluated. Current evidence does not suggest that implanting a cardiovascular electronic device to detect subclinical atrial fibrillation or initiating oral anticoagulation in these patients is beneficial.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: